Healthcare disruption Target large healthcare technology and life sciences firms seeking strategy, M&A advisory, and rapid growth to disrupt the status quo. Popper and Company’s healthcare focus and clinical/scientific expertise position them to partner with firms pursuing innovative diagnostics and patient management solutions.

Small-cap leverage Leverage their lean team size (2-10 employees) as a selling point to engage mid-market or emerging growth clients needing senior-level advisory without the overhead of larger firms. Emphasize flexible engagement models and hands-on, bespoke support.

Strategic advisory play Promote services around strategy and transaction advisory for medical technology companies, leveraging their niche blend of business, clinical, and engineering perspectives to deliver rigorous diligence and accelerative growth.

Network expansion Capitalize on recent hires and evolving senior advisor network to cross-sell through healthcare accelerators, incubators, and clinical networks. Position as a fast-onboarding partner with access to specialized domain experts.

Digital presence promise Highlight the modern tech stack (WordPress/Squarespace, Google Workspace) and strong web footprint as a foundation for scalable client delivery, remote collaboration, and efficient project management to attract digital-health clients seeking agile yet professional advisory partners.